Cromwell LLP / Defendant Valeant USA / PS 14 Management GP LLC / AGMS INC. / PERSHING SQUARE CAPITAL MANAGEMENT L.P. / Defendant AGMS / Pershing Square L.P. / Bausch & Lomb / BoniNi & BOTTINI INC. / Defendant Valeant International / Pershing 25 Square / 3 Allergan / PS FUND 1 LLC / Allergan Inc. / COTCHETT / PITRE & MCCARTHY / LLP / Valeant International 9 / Harcourt LLP / Skadden / Arps / Slate / Meagher & Flom LLP / 16 PS Fund / Pershing Defendants / Pershing Square Holdings Ltd. / Medicis Pharmaceutical Corporation / Valeant USA / Osler / Pershing Square 6 II L.P. / Pearson / VALEANT PHARMACEUTICALS INTERNATIONAL INC. / Valeant International / Pershing Square International Ltd. / PS MANAGEMENT GP LLC / /
Country
Canada / Guernsey / /
Currency
USD / / /
Event
M&A / Employment Change / Business Partnership / Funding / Security Buyback / Person Communication and Meetings / Judicial Event / Reorganization / /
Facility
Airport Office Center / Defendant Pershing Square / If Pershing Square / Together with Pershing Square / Once Pershing Square / /
IndustryTerm
pharmaceutical industry / direct communications / pharmaceuticals / over-the-counter products / law firms / media reports / /
Organization
SOUTHERN DIVISION / San Francisco Airport Office Center / Securities and Exchange Commission / UNITED STATES DISTRICT COURT / Finance and Transactions Committee / Defendant PS Fund / /
Person
ANTHONY BASILE / William F. Doyle / J. Michael / WILLIAM A. ACKMAN / Robert A. Ingram / David E.I. Pyott / Francis A. Bottini / Jr. / Joseph W. Cotchett / Albert Y. Chang / Yury A. Kolesnikov / Mark C. Molumphy / / /
Position
Additional counsel / securities analyst / Chief Executive Officer / CEO / investment adviser / special advisor / counsel / general partner / CEO and Chairman / financial and legal advisors / analyst / member of the board / /
ProvinceOrState
Quebec / British Columbia / New York / California / Delaware / /
Anthony Basile, et al. v. Valeant Pharmaceutical International, Inc., et al. 14-CV[removed]Complaint for Violations of the Federal Securities Laws